Exciting news to report: Pittsburgh is the U.S. site for a clinical trial with a gene-independent, cone sparing therapy for retinitis pigmentosa. SparingVision, a French company developing therapies for ocular […]
SparingVision Clinical Trial
clinical trial
Integrative Ophthalmology
Did you know that the Department of Ophthalmology at the University of Pittsburgh has a Center for Integrative Eye Care? Established in 2007, it was the first in the country. […]
Uveitis Clinical Trial
Marie Hélène Errera, MD, PhD, is awaiting IRB (Institutional Review Board) approval for her clinical trial, which will hopefully start in the next couple of months. The Associate Professor of […]
Using Optogenetics to Restore Vision
The Department of Ophthalmology at the University of Pittsburgh School of Medicine was the first in the world to use optogenetics to restore vision. The Eye & Ear Foundation’s August […]
An Amazing Breakthrough and Big First Step
Sight + Sound, Fall 2021 After 40 years of total blindness, a 58-year-old French man saw stripes in a crosswalk. He was also able to reach out and touch a […]
Two patients in Pittsburgh first in the United States to receive a promising PRIMA system to restore vision for severe Macular Degeneration
Sight + Sound, Spring 2020 by Craig Smith Scientists and clinicians in the Department of Ophthalmology at the University of Pittsburgh School of Medicine had the distinction in January 2020 […]